Glioblastoma Multiforme (GBM) is the most malignant type of astrocytoma (Grade 4 astrocytoma). The most common tumor of the central nervous system (CNS), Glioblastomas account for 15 percent to 20 percent of CNS tumors but just 0.85 to 2 percent of all primary brain tumors.
Glioblastomas usually occur in patients older than 50 and rare in patients younger than 30. Advances by UCLA neurosurgeons, neuro-oncologists, and researchers continue to improve the prognosis of glioblastoma.
The UCLA Brain Tumor Program uses a multidisciplinary team approach to offer state-of-the-art treatment regimens of both standard and experimental treatments.
The Neuro-ICU cares for patients with all types of neurosurgical and neurological injuries, including stroke, brain hemorrhage, trauma and tumors. We work in close cooperation with your surgeon or medical doctor with whom you have had initial contact. Together with the surgeon or medical doctor, the Neuro-ICU attending physician and team members direct your family member's care while in the ICU. The Neuro-ICU team consists of the bedside nurses, nurse practitioners, physicians in specialty training (Fellows) and attending physicians. UCLA Neuro ICU Family Guide